Zhejiang Taimei Medical Technology Co Ltd Class H (2576) Stock Statistics & Valuation Metrics

Zhejiang Taimei Medical Technology Co Ltd Class H has a market cap or net worth of HK$3.54B. The enterprise value is HK$2.21B.

Zhejiang Taimei Medical Technology Co Ltd Class H has 200,592,530 shares outstanding. The number of shares has decreased by -2.65% in one year.

Zhejiang Taimei Medical Technology Co Ltd Class H’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -4.78%.

The current PE Ratio of Zhejiang Taimei Medical Technology Co Ltd Class H is ―. Zhejiang Taimei Medical Technology Co Ltd Class H’s PEG ratio is 0.59.

In the last 12 months, Zhejiang Taimei Medical Technology Co Ltd Class H had revenue of 499.28M and earned -41.74M in profits. Earnings per share was -0.07.

In the last 12 months, operating cash flow was 8.54M and capital expenditures -1.88M, giving a free cash flow of 6.67M billion.

Zhejiang Taimei Medical Technology Co Ltd Class H pays an annual dividend of ―, resulting in a dividend yield of ―

Zhejiang Taimei Medical Technology Co Ltd Class H upcoming earnings date is Mar 30, 2026, Before Open (Not Confirmed).

Zhejiang Taimei Medical Technology Co Ltd Class H as a current ratio of 4.47, with Debt / Equity ratio of 5.45%

In the past 12 months, Zhejiang Taimei Medical Technology Co Ltd Class H has paid 0.00 in taxes.

Zhejiang Taimei Medical Technology Co Ltd Class H EV to EBITDA ratio is -49.50, with an EV/FCF ratio of -33.39.

Zhejiang Taimei Medical Technology Co Ltd Class H has HK$1.19B in cash and marketable securities with HK$61.13M in debt, giving a net cash position of HK$1.13B billion.

Gross margin is 43.74%, with operating margin of -12.32%, and net profit margin of -8.36%.

The average price target for Zhejiang Taimei Medical Technology Co Ltd Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―